Results 181 to 190 of about 7,072 (218)

Obesity increases cardiovascular mortality in patients with HFmrEF

Frontiers in Cardiovascular Medicine, 2022
BackgroundHigh body mass index increases the risk of heart failure morbidity and mortality. It is unclear whether a high body mass index is associated with prognosis in patients with heart failure with mildly reduced left ventricular ejection fraction (HFmrEF).
Zhican Liu, Zhican Liu, Yiqun Peng, Wenjiao Zhao, Yunlong Zhu, Mingxin Wu, Haobo Huang, Ke Peng, Lingling Zhang, Sihao Chen, Sihao Chen, Xin Peng, Xin Peng, Na Li, Na Li, Hui Zhang, Hui Zhang, Yuying Zhou, Yuying Zhou, Yongliang Chen, Yongliang Chen, Sha Xiao, Sha Xiao, Jie Fan, Jianping Zeng, Jianping Zeng   +25 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Dapagliflozin improves outcomes in HFmrEF and HFpEF

Nature Reviews Cardiology, 2022
exaly   +3 more sources

Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF

JACC: Heart Failure, 2018
The purpose of this study was to assess the association between N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cardiovascular (CV) versus non-CV events and between NT-proBNP and potential treatment effects in heart failure (HF) with preserved, mid-range, and reduced ejection fraction (HFpEF, HFmrEF, and HFrEF, respectively) and clinically ...
Gianluigi Savarese, Nicola Orsini, Camilla Hage   +2 more
exaly   +4 more sources

Therapie der diastolischen Herzinsuffizienz (HFpEF/HFmrEF): Lichtstreifen am Horizont?

Aktuelle Kardiologie, 2021
ZusammenfassungEine evidenzbasierte medikamentöse Therapie der diastolischen Herzinsuffizienz (HFpEF/HFmrEF) ist bislang, im Gegensatz zur systolischen Herzinsuffizienz (HFrEF), nicht etabliert. Die ESC-Leitlinien 2016 empfehlen als einzige Substanzklasse Diuretika zur Symptomverbesserung.
openaire   +1 more source

Finerenone improves outcomes in HFmrEF and HFpEF

Nature Reviews Cardiology
exaly   +3 more sources

Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF

JACC: Heart Failure
في حين أنه لا يوصى باستخدام حاصرات بيتا لعلاج HFpEF وفقًا لأحدث إرشادات ESC و AHA/ACC/HFSA، إلا أن هذه العلاجات لا تزال شائعة الاستخدام لإدارة الاعتلال المشترك. كان هناك قلق من أن حاصرات بيتا قد تؤثر سلبًا على النتائج السريرية من خلال الحد من الاستجابة الكرونوتروبية في HFpEF.
Alexander Peikert, Carolyn S P Lam, Adrian F Hernandez   +2 more
exaly   +2 more sources

Prognostic impact of lung ultrasound detected B-Line on hospitalized ischemic HFmrEF patients

European Heart Journal, 2023
Abstract Background The prognostic impact of lung ultrasound derived B-Line (LU-BL) in heart failure patients with mildly reduced left ventricular ejection fraction (HFmrEF) remains elusive. We evaluated the correlation between LU-BL and prognosis in HFmrEF patients.
Y L Zhu, H Zhang, Y Y Zhou, F Q Chen, N Li, X Peng, M X Wu, H B Huang, L L Zhang, M Liao, S H A Xiao, Y L Chen, S H Chen, Z C Liu, J P Zeng   +14 more
openaire   +1 more source

Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF

JACC: Heart Failure
Chronic kidney disease (CKD) is defined by the KDIGO (Kidney Disease: Improving Global Outcomes) guideline as abnormal kidney structure or function, present for >3 months, with implications for health. KDIGO-defined CKD is associated with poor outcomes in patients with heart failure (HF).
Samir Patel, Venkatesh K. Raman, Charles Faselis, Gregg C. Fonarow, Phillip H. Lam, Amiya A. Ahmed, Paul A. Heidenreich, Stefan D. Anker, Prakash Deedwania, Charity J. Morgan, Sijian Zhang, Hans Moore, Janani Rangaswami, George Bakris, Javed Butler, Helen M. Sheriff, Richard M. Allman, Qing Zeng-Treitler, Wen-Chih Wu, Ali Ahmed   +19 more
openaire   +3 more sources

I fenotipi dello scompenso cardiaco: HFrEF, HFmrEF, HfpEF. Diagnosi, prognosi e terapie differenziali

Cardiologia Ambulatoriale, 2023
La classificazione dello scompenso cardiaco (SC) secondo i livelli di frazione di eiezione (FE) non è sufficiente per un corretto inquadramento clinico e per le scelte terapeutiche. Nonostante questo, la suddivisione nelle diverse fasce di FE (FE ridotta, moderatamente ridotta, preservata – HFrEF, HFmrEF, HfpEF) è utile per un iniziale inquadramento ...
openaire   +1 more source

Dapagliflozin DELIVERs for HFmrEF/HFpEF

Medicom Conference Report ESC 2022, 2022
openaire   +1 more source